Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: CLDI )

2.370 +0.180 (+8.22%)
Streaming Delayed Price Updated: 3:14 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,742,950
Open 2.230
Bid (Size) 2.300 (5)
Ask (Size) 2.370 (6)
Prev. Close 2.190
Today's Range 2.200 - 2.470
52wk Range 0.7300 - 26.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Showcases RTNova Virotherapy Breakthrough for Metastatic Cancer Treatment
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
-83.54%
-83.54%
1 Month
+94.26%
+94.26%
3 Month
+53.90%
+53.90%
6 Month
-4.47%
-4.47%
1 Year
-86.83%
-86.83%

More News

Read More
TechMediaBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces Public Offering to Support Immunotherapy Development
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Calidi Biotherapeutics (CLDI) Stock Is Down 13%
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Is ‘One to Watch’
Via Investor Brand Network
InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program
Via Investor Brand Network
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present Antitumor Virotherapy Platform Data at Three Scientific Conferences
Via Investor Brand Network
Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024
Via InvestorPlace
GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names New Medical Advisory Board Member
Via Investor Brand Network
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower
Via Benzinga
Calidi to Effect Reverse Stock Split
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13
From Calidi Biotherapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.